Aaron B Holley, Emil Oweis, Erann Briggs, Michael J McMahon, Michael J Morris
{"title":"使用种族中立预测方程解释现役军人肺活量测定的效果。","authors":"Aaron B Holley, Emil Oweis, Erann Briggs, Michael J McMahon, Michael J Morris","doi":"10.1016/j.rmed.2025.108400","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of our analysis was to study the clinical and occupational consequences from switching to a \"race-neutral\" spirometry reference equation for active-duty service members (ADSMs).</p><p><strong>Methods: </strong>We hypothesized that switching to a \"race-neutral\" equation would affect eligibility for deployment and improve clinical accuracy. We tested this hypothesis using data from a prospective cohort study (STAMPEDE II) of ADSMs screened using spirometry pre-deployment. Prevalence of abnormality and z-scores were compared using the \"race-neutral\" GLI-Global (GLI-G) versus the original GLI 2012 (GLI-R) equations. The relationship between spirometry and deployment respiratory symptoms was modeled using ordinal logistic regression.</p><p><strong>Results: </strong>Among the 1,632 subjects enrolled in STAMPEDE II, moving to GLI-G decreased z-scores and increased the prevalence of abnormality for Black ADSMs. For White and Hispanic ADSMs, z-scores increased and resulting abnormalities decreased. Among those referred for pre-deployment spirometry per current military protocols (n=155), using GLI-G increased abnormal spirometry from 9.8% to 11.6% (p<0.01), with a significant increase (5 (16.7%) to 14 (46.7%); p=0.01) and decrease (6 (6.5%) to 3 (3.2%); p=0.01) in abnormal spirometry in Black and White subjects, respectively. After adjustment for other factors, the presence of abnormal spirometry, whether defined by GLI-G or GLI-R, did not increase the odds for an increase in respiratory symptoms during or after deployment.</p><p><strong>Discussion: </strong>Among Black ADSMs, GLI-G decreases z-scores and results in an increase in abnormalities that will affect eligibility for deployment. Moving to a \"race-neutral\" equation did not improve clinical accuracy for predicting respiratory symptoms during or after deployment.</p>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":" ","pages":"108400"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects from Using a Race-Neutral Prediction Equation for Interpreting Spirometry in an Active-Duty Military Population.\",\"authors\":\"Aaron B Holley, Emil Oweis, Erann Briggs, Michael J McMahon, Michael J Morris\",\"doi\":\"10.1016/j.rmed.2025.108400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The purpose of our analysis was to study the clinical and occupational consequences from switching to a \\\"race-neutral\\\" spirometry reference equation for active-duty service members (ADSMs).</p><p><strong>Methods: </strong>We hypothesized that switching to a \\\"race-neutral\\\" equation would affect eligibility for deployment and improve clinical accuracy. We tested this hypothesis using data from a prospective cohort study (STAMPEDE II) of ADSMs screened using spirometry pre-deployment. Prevalence of abnormality and z-scores were compared using the \\\"race-neutral\\\" GLI-Global (GLI-G) versus the original GLI 2012 (GLI-R) equations. The relationship between spirometry and deployment respiratory symptoms was modeled using ordinal logistic regression.</p><p><strong>Results: </strong>Among the 1,632 subjects enrolled in STAMPEDE II, moving to GLI-G decreased z-scores and increased the prevalence of abnormality for Black ADSMs. For White and Hispanic ADSMs, z-scores increased and resulting abnormalities decreased. Among those referred for pre-deployment spirometry per current military protocols (n=155), using GLI-G increased abnormal spirometry from 9.8% to 11.6% (p<0.01), with a significant increase (5 (16.7%) to 14 (46.7%); p=0.01) and decrease (6 (6.5%) to 3 (3.2%); p=0.01) in abnormal spirometry in Black and White subjects, respectively. After adjustment for other factors, the presence of abnormal spirometry, whether defined by GLI-G or GLI-R, did not increase the odds for an increase in respiratory symptoms during or after deployment.</p><p><strong>Discussion: </strong>Among Black ADSMs, GLI-G decreases z-scores and results in an increase in abnormalities that will affect eligibility for deployment. Moving to a \\\"race-neutral\\\" equation did not improve clinical accuracy for predicting respiratory symptoms during or after deployment.</p>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\" \",\"pages\":\"108400\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.rmed.2025.108400\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.rmed.2025.108400","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Effects from Using a Race-Neutral Prediction Equation for Interpreting Spirometry in an Active-Duty Military Population.
Introduction: The purpose of our analysis was to study the clinical and occupational consequences from switching to a "race-neutral" spirometry reference equation for active-duty service members (ADSMs).
Methods: We hypothesized that switching to a "race-neutral" equation would affect eligibility for deployment and improve clinical accuracy. We tested this hypothesis using data from a prospective cohort study (STAMPEDE II) of ADSMs screened using spirometry pre-deployment. Prevalence of abnormality and z-scores were compared using the "race-neutral" GLI-Global (GLI-G) versus the original GLI 2012 (GLI-R) equations. The relationship between spirometry and deployment respiratory symptoms was modeled using ordinal logistic regression.
Results: Among the 1,632 subjects enrolled in STAMPEDE II, moving to GLI-G decreased z-scores and increased the prevalence of abnormality for Black ADSMs. For White and Hispanic ADSMs, z-scores increased and resulting abnormalities decreased. Among those referred for pre-deployment spirometry per current military protocols (n=155), using GLI-G increased abnormal spirometry from 9.8% to 11.6% (p<0.01), with a significant increase (5 (16.7%) to 14 (46.7%); p=0.01) and decrease (6 (6.5%) to 3 (3.2%); p=0.01) in abnormal spirometry in Black and White subjects, respectively. After adjustment for other factors, the presence of abnormal spirometry, whether defined by GLI-G or GLI-R, did not increase the odds for an increase in respiratory symptoms during or after deployment.
Discussion: Among Black ADSMs, GLI-G decreases z-scores and results in an increase in abnormalities that will affect eligibility for deployment. Moving to a "race-neutral" equation did not improve clinical accuracy for predicting respiratory symptoms during or after deployment.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.